In our study, the phosphorylated form of IGFBP-1 was lower in women with GDM as compared to their healthy counterparts at late pregnancy and was a more effective predictor of GDM than the non-phosphorylated form, supporting the previous findings of phIGFBP in GDM. Here, IGFBP1 is linked to gestational diabetes.